2023
DOI: 10.1016/j.lfs.2023.122253
|View full text |Cite
|
Sign up to set email alerts
|

Identification of the role of MCM6 in bladder cancer prognosis, immunotherapy response, and in vitro experimental investigation using multi-omics analysis

Jirong Wang,
Xiaoran Li,
Siyu Chen
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 44 publications
0
1
0
Order By: Relevance
“…A similar basis can be used for CDC25 as was used for MCM6 (mini-chromosome maintenance), a vital protein for chromosome stability. Proteomics has linked other members within this protein family, finding overexpression between cancerous and normal tissue, particularly in bowel cancer (Wang et al, 2023). The utility of proteomics was not just singled out to this check-point inhibitor, Proteolysis targeting chimera D6 in triple-negative breast cancer along a CDC25-CDK1 axis was found by comparing triple-negative breast cancer cell line response against D6 (Wu Y. et al, 2024).…”
Section: Introduction To Molecular Profiling Techniques For Identifyi...mentioning
confidence: 99%
“…A similar basis can be used for CDC25 as was used for MCM6 (mini-chromosome maintenance), a vital protein for chromosome stability. Proteomics has linked other members within this protein family, finding overexpression between cancerous and normal tissue, particularly in bowel cancer (Wang et al, 2023). The utility of proteomics was not just singled out to this check-point inhibitor, Proteolysis targeting chimera D6 in triple-negative breast cancer along a CDC25-CDK1 axis was found by comparing triple-negative breast cancer cell line response against D6 (Wu Y. et al, 2024).…”
Section: Introduction To Molecular Profiling Techniques For Identifyi...mentioning
confidence: 99%